BDO Wealth Advisors’s Blueprint Medicines BPMC Stock Holding History

BDO Wealth Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-33	Closed	-$3K	–	621
2019 Q2	$3K	Buy	+33	New	+$2.72K	﹤0.01%	554

Other funds holding BPMC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BDO Wealth Advisors's BPMC Position: Q3 2019 in Review

BDO Wealth Advisors sold out of Blueprint Medicines (BPMC) in Q3 2019, closing a stake of 33 shares — an estimated $3K sold.

BDO Wealth Advisors first reported a position in BPMC in Q2 2019 and held it in 1 quarter. The position peaked at $3K in Q2 2019. 219 funds tracked by Wall St. Rank hold BPMC as of Q3 2019.

BDO Wealth Advisors reported no remaining Blueprint Medicines position as of Q3 2019 after selling out during the quarter.
BDO Wealth Advisors sold 33 Blueprint Medicines shares in Q3 2019, an estimated $3K.
BDO Wealth Advisors first reported a position in Blueprint Medicines in Q2 2019 and held it in 1 quarter.
BDO Wealth Advisors's Blueprint Medicines position peaked at $3K in Q2 2019.
219 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2019.

Based on BDO Wealth Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.